Insider · CIK 0001853109

Derakhshan Behrad

Reports to the SEC for 1 company · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001853109

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-12	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,781 sh	—	—	29,426
2026-08-12	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+7,500 sh	—	—	36,926
2026-08-12	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−2,171 sh	$43.79	−$95.1K	34,755
2026-08-12	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−304 sh	$44.50	−$13.5K	34,451
2026-08-12	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−150 sh	$44.44	−$6,666.495	34,301
2026-08-12	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−2,475 sh	$43.70	−$108K	31,826
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,781 sh	—	—	11,563
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−7,500 sh	—	—	22,500
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Business Officer	AAward	+50K sh	—	—	50,000
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+100K sh	—	—	100,000
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+100K sh	—	—	100,000
2025-08-12	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,781 sh	—	—	26,136
2025-08-12	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−2,491 sh	$13.39	−$33.4K	23,645
2025-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,781 sh	—	—	17,344
2025-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Business Officer	AAward	+30K sh	—	—	30,000
2025-08-12	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+180K sh	—	—	180,000
2025-05-02	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−1,691 sh	$16.45	−$27.8K	20,355
2025-05-01	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,209 sh	—	—	22,046
2025-05-01	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,209 sh	—	—	0
2025-02-05	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+10K sh	$1.93	+$19.3K	26,837
2025-02-05	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−10K sh	$30.03	−$300K	16,837
2025-02-05	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−10K sh	—	—	92,929
2024-09-20	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+42.1K sh	$1.93	+$81.2K	57,189
2024-09-20	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−42.1K sh	$29.03	−$1.22M	15,121
2024-09-20	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−42.1K sh	—	—	102,949
2024-08-12	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+139K sh	—	—	138,750
2024-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Business Officer	AAward	+23.1K sh	—	—	23,125
2024-05-02	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−1,718 sh	$18.91	−$32.5K	13,422
2024-05-01	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,208 sh	—	—	15,140
2024-05-01	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,208 sh	—	—	5,209
2024-02-09	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+4,800 sh	$1.93	+$9,264	11,820
2024-02-09	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−4,800 sh	$20.04	−$96.2K	7,020
2024-02-09	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−4,800 sh	—	—	145,017
2024-02-08	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+4,600 sh	$1.93	+$8,878	11,620
2024-02-08	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−4,600 sh	$20.01	−$92K	7,020
2024-02-08	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−4,600 sh	—	—	149,817
2024-02-07	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+600 sh	$1.93	+$1,158	7,620
2024-02-07	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−600 sh	$20.00	−$12K	7,020
2024-02-07	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−600 sh	—	—	154,417
2023-08-17	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+220K sh	—	—	220,000
2023-05-02	EWTXEdgewise Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−1,747 sh	$8.90	−$15.6K	7,020
2023-05-01	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,208 sh	—	—	8,767
2023-05-01	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,208 sh	—	—	10,417
2022-08-08	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+200K sh	—	—	200,000
2022-05-01	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Business Officer	AAward	+15.6K sh	—	—	15,625
2021-08-17	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+140K sh	—	—	140,000

Recent filings

Accepted (ET)
Aug 174/A
Derakhshan Behrad0001853109-26-000002
SEC(opens sec.gov)
Aug 144
Derakhshan Behrad0001853109-26-000001
SEC(opens sec.gov)
Aug 144
Derakhshan Behrad0001562180-25-005798
SEC(opens sec.gov)
May 74
Derakhshan Behrad0001562180-25-003656
SEC(opens sec.gov)
Feb 74
Derakhshan Behrad0001562180-25-001024
SEC(opens sec.gov)

Companies

Edgewise Therapeutics, Inc.Chief Business OfficerEWTX

Address

C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET

BOULDER, CO, 80301